CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
6.46
+0.16 (2.54%)
At close: Mar 6, 2026, 4:00 PM EST
6.37
-0.09 (-1.39%)
After-hours: Mar 6, 2026, 7:59 PM EST
CorMedix Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for CorMedix stock have an average target of 15.14, with a low estimate of 12 and a high estimate of 22. The average target predicts an increase of 134.37% from the current stock price of 6.46.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CorMedix stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Maintains $15 → $14 | Strong Buy | Maintains | $15 → $14 | +116.72% | Mar 5, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +116.72% | Feb 11, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $13 | Strong Buy | Maintains | $18 → $13 | +101.24% | Jan 23, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $22 → $13 | Buy | Maintains | $22 → $13 | +101.24% | Jan 21, 2026 |
| Needham | Needham | Strong Buy Maintains $16 → $15 | Strong Buy | Maintains | $16 → $15 | +132.20% | Jan 8, 2026 |
Financial Forecast
Revenue This Year
315.14M
from 311.71M
Increased by 1.10%
Revenue Next Year
291.53M
from 315.14M
Decreased by -7.49%
EPS This Year
1.36
from 2.04
Decreased by -33.29%
EPS Next Year
1.08
from 1.36
Decreased by -20.74%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 330.7M | 321.0M | |||
| Avg | 315.1M | 291.5M | |||
| Low | 299.3M | 270.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 6.1% | 1.9% | |||
| Avg | 1.1% | -7.5% | |||
| Low | -4.0% | -14.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.72 | 1.24 | |||
| Avg | 1.36 | 1.08 | |||
| Low | 1.06 | 0.92 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -15.6% | -9.0% | |||
| Avg | -33.3% | -20.7% | |||
| Low | -48.1% | -32.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.